These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

643 related articles for article (PubMed ID: 20517933)

  • 1. Clinical progression in Parkinson disease and the neurobiology of axons.
    Cheng HC; Ulane CM; Burke RE
    Ann Neurol; 2010 Jun; 67(6):715-25. PubMed ID: 20517933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Axon degeneration in Parkinson's disease.
    Burke RE; O'Malley K
    Exp Neurol; 2013 Aug; 246():72-83. PubMed ID: 22285449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrograde Axonal Degeneration in Parkinson Disease.
    Tagliaferro P; Burke RE
    J Parkinsons Dis; 2016; 6(1):1-15. PubMed ID: 27003783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracellular signalling pathways in dopamine cell death and axonal degeneration.
    Burke RE
    Prog Brain Res; 2010; 183():79-97. PubMed ID: 20696316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An order in Lewy body disorders: Retrograde degeneration in hyperbranching axons as a fundamental structural template accounting for focal/multifocal Lewy body disease.
    Uchihara T
    Neuropathology; 2017 Apr; 37(2):129-149. PubMed ID: 27862327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Propagation of alpha-synuclein pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies.
    Uchihara T; Giasson BI
    Acta Neuropathol; 2016 Jan; 131(1):49-73. PubMed ID: 26446103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the Akt/GSK-3β/CRMP-2 pathway in axon degeneration of dopaminergic neurons resulting from MPP+ toxicity.
    Fang W; Gao G; Zhao H; Xia Y; Guo X; Li N; Li Y; Yang Y; Chen L; Wang Q; Li L
    Brain Res; 2015 Mar; 1602():9-19. PubMed ID: 25150591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptosis versus axon pruning: Molecular intersection of two distinct pathways for axon degeneration.
    Geden MJ; Romero SE; Deshmukh M
    Neurosci Res; 2019 Feb; 139():3-8. PubMed ID: 30452947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Axon death signalling in Wallerian degeneration among species and in disease.
    Llobet Rosell A; Neukomm LJ
    Open Biol; 2019 Aug; 9(8):190118. PubMed ID: 31455157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The necroptosis machinery mediates axonal degeneration in a model of Parkinson disease.
    Oñate M; Catenaccio A; Salvadores N; Saquel C; Martinez A; Moreno-Gonzalez I; Gamez N; Soto P; Soto C; Hetz C; Court FA
    Cell Death Differ; 2020 Apr; 27(4):1169-1185. PubMed ID: 31591470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of gene expression in Parkinson's disease: possible involvement of neurotrophic support and axon guidance in dopaminergic cell death.
    Bossers K; Meerhoff G; Balesar R; van Dongen JW; Kruse CG; Swaab DF; Verhaagen J
    Brain Pathol; 2009 Jan; 19(1):91-107. PubMed ID: 18462474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for dopaminergic axonal degeneration as an early pathological process in Parkinson's disease.
    O'Keeffe GW; Sullivan AM
    Parkinsonism Relat Disord; 2018 Nov; 56():9-15. PubMed ID: 29934196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Wld(S) mutation delays anterograde, but not retrograde, axonal degeneration of the dopaminergic nigro-striatal pathway in vivo.
    Cheng HC; Burke RE
    J Neurochem; 2010 May; 113(3):683-91. PubMed ID: 20132467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging evidence for compromised axonal bioenergetics and axoglial metabolic coupling as drivers of neurodegeneration.
    Beirowski B
    Neurobiol Dis; 2022 Aug; 170():105751. PubMed ID: 35569720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is Axonal Degeneration a Key Early Event in Parkinson's Disease?
    Kurowska Z; Kordower JH; Stoessl AJ; Burke RE; Brundin P; Yue Z; Brady ST; Milbrandt J; Trapp BD; Sherer TB; Medicetty S
    J Parkinsons Dis; 2016 Oct; 6(4):703-707. PubMed ID: 27497486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin protects axons from degeneration in the setting of local neuroinflammation.
    Tegenge MA; Rajbhandari L; Shrestha S; Mithal A; Hosmane S; Venkatesan A
    Exp Neurol; 2014 Mar; 253():102-10. PubMed ID: 24382451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine acetylcholine imbalance in Parkinson's disease. Possible regenerative overgrowth of cholinergic axon terminals.
    Spehlmann R; Stahl SM
    Lancet; 1976 Apr; 1(7962):724-6. PubMed ID: 56538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of degenerative spheroids after injury.
    Yong Y; Gamage K; Cushman C; Spano A; Deppmann C
    Sci Rep; 2020 Sep; 10(1):15472. PubMed ID: 32963272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Programmed axon death, synaptic dysfunction and the ubiquitin proteasome system.
    Coleman MP; Ribchester RR
    Curr Drug Targets CNS Neurol Disord; 2004 Jun; 3(3):227-38. PubMed ID: 15180483
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 33.